Association of plasma ceramide with decline in kidney function in patients with type 2 diabetes
Circulating ceramide levels are dysregulated in kidney disease. However, their associations with rapid decline in kidney function (RDKF) and end-stage kidney disease (ESKD) in patients with type 2 diabetes (T2D) are unknown. In this prospective study of 1746 T2D participants, we examined the associa...
Main Authors: | Gurung, Resham L., Yiamunaa, M., Tham, Wai Kin, Liu, Sylvia, Zheng, Huili, Lee, Janus, Ang, Keven, Wenk, Markus, Subramaniam, Tavintharan, Sum, Chee Fang, Torta, Federico, Liu, Jian-Jun, Lim, Su Chi |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/181762 |
Similar Items
-
Ceramide acyl chain length and its relevance to intracellular lipid regulation
by: Ho, Calvin Qing Wei, et al.
Published: (2023) -
Incident heart failure and the subsequent risk of progression to end stage kidney disease in individuals with type 2 diabetes
by: Liu, Sylvia, et al.
Published: (2024) -
A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes
by: van Zuydam, Natalie R., et al.
Published: (2020) -
Association between kidney disease index and decline in cognitive function with mediation by arterial stiffness in Asians with type 2 diabetes
by: Low, Serena, et al.
Published: (2024) -
Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients
by: Sharma, Kumar, et al.
Published: (2024)